4th Pediatric Infectious Diseases Conference
 
 
Home  Back   ISSN 0973 - 0958
 
User name :
Password :
THROMBOTIC THROMBOCYTOPENIC PURPURA
Follow Us : Follow On Facebook Follow On Twitter Follow On Youtube
THROMBOTIC THROMBOCYTOPENIC PURPURA & PLASMAPHERSIS IN PEDIATRICS
NCPCC-12


Rajeswari N, Suchitra R, Deepika, Revathy R
Dept of PICU Pediatric Hem-Oncology and Bone Marrow Transplant Unit,
Apollo Hospitals, Chennai

Introduction:


Thrombotic thrombocytopenic purpura (TTP) is a relatively rare multisystem disorder. It is a true medical emergency but poorly described in children. Diagnosis may be delayed or missed as children with TTP usually present with symptoms that are common to many other disease states. Although recent improvements in the understanding of the fundamental lesson in TTP have led to dramatic improvements in its diagnosis and treatment, mortality remains high even when appropriately managed.

Methods:

We presented 4 children with TTP that required Intensive Care over the last 12 months. Of these, one had congenital TTP, two idiopathic TTP and one had TTP following allogenic bone marrow transplantation.

Patients were admitted to the ICU because of fever, acute onset neurological symptoms pallor and thrombocytopenia. Additional features were acute renal failure and metabolic derangement with laboratory features of elevated lactate dehydrogenase and schistocytosis.

Mechanical ventilation was required in three cases. Specific treatment depended on the type of TTP with repeated transfusions of fresh frozen plasma in congenital TTP, fresh plasma and plasma exchange in idiopathic TTP and immunosuppressive therapy in post BMT patient.

The neurological symptoms disappeared in all patients and renal function normalized rapidly. However, 2 patients died, one within 24 hours of initiation of therapy. One patient relapsed thrice and required multiple sittings of plasmapheresis.

Conclusion: TTP is a relatively rare, but life-threatening disorder that may be encountered by ICU practitioners. Awareness, prompt diagnosis and aggressive treatment may help control the high mortality associated with this challenging disorder.

Last Updated on 15-05-2006

How to cite this url
NCPCC 2005 - Conference Abstracts. Pediatric Oncall [serial online] 2006 [cited 15 May 2006(Supplement 5)];3. Available from:
http://www.pediatriconcall.com/fordoctor/Conference_abstracts/
TTP_plasmapheresis.asp
 
 
 
Pedi Poll
Today's Poll
Should teicoplannin, colistin be used in case of neonatal sepsis where culture does not reveal any organism_?
No, it should be used only after drug sensitivity report
Yes, under guidance of an infectious disease expert
Educational Section
 
Disclaimer:
The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
 
copyright ©2011 website design & development by Levioza
Follow Us
Follow us on :
Folllow Us